from Burlington, MA
Thomas Megerian & Chuck Bramlage Yamo Pharmaceuticals Topic: L1-79 for...
Yamo proposes L1-79, a racemic mixture of DL-alpha Methyltyrosine e (D...
UCLA Tarjan Center J. Thomas Megerian, MD, PhD "Building A Co-Occurrin...
Mukesh Jain, MD, FAHA, Chief Academic Officer, University Hospitals in...
Dr. Megerian describes why health care leaders need to think strategic...
Jumping into the magic and craft world of rugs and carpets exclusively...